Supplemental material
Hematology
Volume 29, 2024 - Issue 1
Open access
1,134
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
Mihee Kima Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of KoreaView further author information
, Seo-Yeon Ahna Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of KoreaView further author information
, TaeHyung Kimb Department of Computer Science, University of Toronto, Toronto, Canada;c The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, CanadaView further author information
, Sung-Hoon Junga Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of KoreaView further author information
, Ga-Young Songa Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of KoreaView further author information
, Deok-Hwan Yanga Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of KoreaView further author information
, Je-Jung Leea Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of KoreaView further author information
, Mi Yeon Kimd Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of KoreaView further author information
, Ju Heon Parkd Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of KoreaView further author information
, Myung-Geun Shind Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of KoreaView further author information
, Jae-Sook Ahna Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of Korea;d Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of KoreaCorrespondence[email protected] [email protected]
View further author information
, View further author information
Hyeoung-Joon Kima Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of Korea;d Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of KoreaView further author information
& Dennis Dong Hwan Kime Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, CanadaView further author information
show all
Article: 2324417
|
Received 08 Aug 2023, Accepted 23 Feb 2024, Published online: 03 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.